Subject of the day
GNS.L
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
$2,254.00
▼ -2.00 (-0.1%)
| 52w hi | $3,169.87 |
|---|---|
| 52w lo | $1,966.00 |
| Vol | 72.91K |
| As of | Aug 13 |
Our score -0.32
| Short | -0.50 |
|---|---|
| Medium | -0.24 |
| Long | -0.13 |
computed 2026-08-13
Genus plc
Healthcare · Biotechnology
| Market cap | $1.50B |
|---|---|
| Enterprise value | $1.71B |
| Trailing P/E | 31.75x |
| Forward P/E | 21.59x |
| EV / EBITDA | 17.77x |
| P / S (ttm) | 2.23x |
| Profit margin | 7.1% |
| Return on equity | 9.3% |
| Revenue growth | -0.2% |
| Earnings growth | +1754.2% |
| Debt / equity | 51.74 |
| Beta vs SPX | 0.22 |
|---|---|
| Corr SPX | 0.08 |
| Annual vol | 42.4% |
| Annual ret | +21.0% |
| Sharpe | 0.50 |
| Max DD | -38.3% |
Window: 504 trading days (491 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.12 | |
| Sector | +0.12 | |
| Technical | -0.28 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $2,200.00 | $2,302.00 | $2,200.00 | $2,254.00 | 72.91K |
| Aug 12 | $2,302.00 | $2,372.00 | $2,240.00 | $2,256.00 | 86.78K |
| Aug 11 | $2,362.00 | $2,362.00 | $2,280.77 | $2,296.00 | 69.69K |
| Aug 10 | $2,308.00 | $2,344.00 | $2,283.20 | $2,318.00 | 227.47K |
| Aug 7 | $2,316.00 | $2,334.00 | $2,284.00 | $2,304.00 | 255.23K |